Topiramate lithium

Overview

Topiramate (McN 4853) lithium is a broad-spectrum antiepileptic agent. Topiramate lithium is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels , increases in potassium conductance, and inhibition of carbonic anhydrase .

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Carbonic Anhydrase | Products > Signaling Pathways > iGluR | Products > Signaling Pathways > GABA Receptor | Products > Signaling Pathways > Sodium Channel | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > Potassium Channel

Product Information

• Catalog No.: HY-B0122A
• CAS No.: 488127-53-3
• Molecular Formula: C12H21LiNO8S
• Molecular Weight: 346.30
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source